BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21647008)

  • 41. Practical aspects of dealing with cancer therapy-induced nausea and vomiting.
    Pervan V
    Semin Oncol Nurs; 1990 Nov; 6(4 Suppl 1):3-5. PubMed ID: 2277872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nausea, vomiting, and retching: the management of the symptom experience.
    Rhodes VA; Johnson MH; McDaniel RW
    Semin Oncol Nurs; 1995 Nov; 11(4):256-65. PubMed ID: 8578033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy-related nausea and vomiting - past reflections, present practice and future management.
    Miller M; Kearney N
    Eur J Cancer Care (Engl); 2004 Mar; 13(1):71-81. PubMed ID: 14961778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.
    Andersen RL; Johnson DJ; Patel JN
    Pharmacogenomics; 2016 Mar; 17(4):417-34. PubMed ID: 26871520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tools for assessing nausea, vomiting, and retching.
    Wood JM; Chapman K; Eilers J
    Cancer Nurs; 2011; 34(1):E14-24. PubMed ID: 21188798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention and control of nausea and vomiting for patients with cancer.
    Goebel C
    Home Healthc Nurse; 1996 Jan; 14(1):15-20; quiz 21-2. PubMed ID: 8698602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How should nausea be assessed in patients receiving chemotherapy?
    Kaye SB
    Cancer Treat Rev; 1991 Jun; 18(2):85-93. PubMed ID: 1804526
    [No Abstract]   [Full Text] [Related]  

  • 48. The colorectal cancer clinical nurse specialist in chemotherapy.
    Wright K; Myint AS
    Hosp Med; 2003 Jun; 64(6):333-6. PubMed ID: 12833825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy induced nausea and vomiting: a European perspective.
    Vidall C
    Br J Nurs; 2011 May 27-Jun 9; 20(10):S22, S25-8. PubMed ID: 21647008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
    Viale PH
    Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
    Viale PH; Grande C; Moore S
    Clin J Oncol Nurs; 2012 Aug; 16(4):E133-41. PubMed ID: 22842698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.